您的位置：首页 > 产品中心 > 86215-36-3， DOV 216,303
DOV 216,303
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 3079806 | 5 MG | 1810 | |||
| 3079806 | 25 MG | 7290 |
产品别名
86215-36-3
DOV 216,303
(±)-1-(3,4-dichlorophenyl)-3-azabicyclo-[3.1.0]hexane hydrochloride
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C11H11Cl2N · HCl |
| Molecular weight | 264.58 |
| MDL number | MFCD06407666 |
| PubChem Substance ID【PubChem化学物质编号】 | 329798827 |
| NACRES | NA.77 |
| Biochem/physiol Actions【生化/生理作用】 | Triple reuptake inhibitor (TRI); serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI); IC50 values of ~20, 14, and 78 nM, respectively. |
| Features and Benefits【特点和优势】 | This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. This compound is featured on the Dopamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| color【颜色】 | white to beige |
| solubility【溶解性】 | DMSO: ≥10 mg/mL |
| originator【创始人】 | Merck & Co., Inc., Kenilworth, NJ, U.S. |
| storage temp.【储存温度】 | −20℃ |
| SMILES string | Cl.Clc1ccc(cc1Cl)C23CNCC2C3 |
| InChI | 1S/C11H11Cl2N.ClH/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11;/h1-3,8,14H,4-6H2;1H |
| InChI key | KAGBHVBIOJBGBD-UHFFFAOYSA-N |
| packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS06 |
| Signal word【警示用语：】 | Danger |
| Hazard Statements | H301 - H319 |
| Precautionary Statements | P301 + P310 + P330 - P305 + P351 + P338 |
| Hazard Classifications【危险分类】 | Acute Tox. 3 Oral - Eye Irrit. 2 |
| Storage Class Code【储存分类代码】 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
| WGK | WGK 3 |
